Impact of COVID-19 on young cancer patients and survivors
Official title: Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors
Run by M.D. Anderson Cancer Center · NCT04551378 · Data updated 2026-11-12
This study is trying to see how the COVID-19 pandemic has affected the mental, physical, and social well-being of young cancer patients and survivors aged 18 to 39.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | July 13, 2020 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT04551378 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are AYA cancer patients and survivors aged 18 to 39 who were diagnosed between the ages of 15 to 39 and have received treatment at MD Anderson Cancer Center.
✕Probably not a fit
Patients who are unable to complete questionnaires in English or those who visited MD Anderson for non-treatment related reasons may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines how the COVID-19 pandemic has affected the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. Participants, aged 18 to 39 who were diagnosed with cancer between 15 to 39 years old, will complete an online survey assessing their COVID-19 specific psychological distress, healthcare utilization, health behaviors, and quality of life. The study aims to identify associations between demographic factors and resilience with these outcomes, and may lead to targeted interventions to improve the well-being of this vulnerable population.
Why it matters
Potential benefit: If successful, this study could lead to improved psychosocial health interventions for AYA cancer patients and survivors affected by the pandemic.
How similar studies have gone: While the specific focus on AYA cancer patients during the COVID-19 pandemic is novel, similar studies have shown success in understanding the psychosocial impacts of health crises on vulnerable populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * PATIENT COHORT INCLUSION: * Initial cancer diagnosis between the ages of 15 to 39 * Received any cancer treatment at MD Anderson Cancer Center with data available in the MD Anderson Cancer Center Tumor Registry * For questionnaire provision: confirmed alive at time of contact Exclusion Criteria: * PATIENT COHORT EXCLUSION: * Inability to complete questionnaires in English * Seen at MD Anderson for a second opinion or non-treatment related visit
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Michael E Roth, MD — M.D. Anderson Cancer Center
- Study coordinator: Michael E Roth, MD
- Email: MRoth1@mdanderson.org
- Phone: 713-792-7751
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining how COVID-19 changed pulmonary procedures
This study looks at how doctors who treat lung conditions changed their procedures and staffing during the COVID-19 pandemic to see what worked best.
-
Video education to boost knowledge and interest in cancer clinical trials
Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.
-
Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion
This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.
-
Using weighted blankets to reduce anxiety in cancer patients during infusions
This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.
-
Letermovir to prevent cytomegalovirus after pediatric stem cell transplant
This study will try giving letermovir to CMV-positive children and adolescents receiving allogeneic stem cell transplants to see if it lowers CMV infections after transplant compared with the expected rate without prophylaxis.
-
Collecting blood and tissue samples for HIV/AIDS-related cancer research
This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.